Transmedics Group Inc (NASDAQ: TMDX) Could Be Viewed Differently By Investors Because Of These Numbers

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

Stocks Info

The company is listed on the NASDAQ and operates within the Medical Devices industry segment. The current market capitalization of Transmedics Group Inc is $2.32B. A total of 0.78 million shares were traded on the day, compared to an average of 1.80M shares.

In the most recent transaction, Khayal Tamer I sold 2,407 shares of TMDX for 76.43 per share on Mar 03 ’25. After the transaction, the Chief Commercial Officer now owns 36,042 company shares. In a previous transaction on Mar 04 ’25, Gordon Stephen bought 5,942 shares at 65.61 per share.

Among the insiders who sold shares, Khayal Tamer I disposed of 1,083 shares on Jan 07 ’25 at a per-share price of $80.05. This resulted in the Chief Commercial Officer holding 20,843 shares of TMDX after the transaction. In another insider transaction, Khayal Tamer I sold 1,084 shares at $86.40 per share on Dec 02 ’24. Company shares held by the Chief Commercial Officer now total 20,843.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, TMDX has a high of $177.37 and a low of $55.00.

As of this writing, TMDX has an earnings estimate of $0.24 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of $0.34 per share and a lower estimate of $0.12.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. TMDX’s latest balance sheet shows that the firm has $92.45M in Cash & Short Term Investments as of fiscal 2021. There were $43.80M in debt and $23.24M in liabilities at the time. Its Book Value Per Share was $6.80, while its Total Shareholder’s Equity was $67.85M.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TMDX is Buy with a score of 4.33.

Most Popular

Related Posts